2022
DOI: 10.3892/etm.2022.11389
|View full text |Cite
|
Sign up to set email alerts
|

Possible association between Guillain‑Barré syndrome and SARS‑CoV‑2 infection in children: A case report and literature review

Abstract: Neurological manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have been reported in adults and in children, varying from mild to more debilitant symptoms, including fatigue, headache and dizziness. A series of studies have revealed a possible association between Guillain-Barré syndrome (GBS), the most common cause of acute flaccid paralysis at all ages, and SARS-CoV-2 infection. Case reports of novel coronavirus disease 2019 (COVID-19)-associated GBS mainly include adult… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 28 publications
0
1
0
Order By: Relevance
“…Guillain-Barré syndrome with classic clinical, CSF and radiological alterations was diagnosed in one child. The association between SARS-CoV-2 infection and GBS is well-known in the literature, and about hundred and twenty cases have been reported, respectively, in the adult and pediatric populations [ 53 , 54 ]. Our patient had a shorter latency between systemic symptoms and neurological disease onset compared to the median latency reported by a systematic review [ 53 ], but these authors highlights even earlier neurological manifestations.…”
Section: Discussionmentioning
confidence: 99%
“…Guillain-Barré syndrome with classic clinical, CSF and radiological alterations was diagnosed in one child. The association between SARS-CoV-2 infection and GBS is well-known in the literature, and about hundred and twenty cases have been reported, respectively, in the adult and pediatric populations [ 53 , 54 ]. Our patient had a shorter latency between systemic symptoms and neurological disease onset compared to the median latency reported by a systematic review [ 53 ], but these authors highlights even earlier neurological manifestations.…”
Section: Discussionmentioning
confidence: 99%